Pharmacist Outreach and SGLT2 Inhibitor Uptake in Patients With Diabetes and Chronic Kidney Disease - Top-Institutions - MDSpire

Pharmacist Outreach and SGLT2 Inhibitor Uptake in Patients With Diabetes and Chronic Kidney Disease

  • By

  • Deborah L. Pestka

  • Daniel Murphy

  • Adam N. Kaplan

  • Brent C. Taylor

  • Pearl Huynh

  • Jessica A. Rechtzigel

  • Shari Kjos

  • Lisa Marie Ellich

  • Melissa Atwood

  • Beth A. Polsfuss

  • Amber R. Thomas

  • Joseph Y. Lee

  • Areef Ishani

  • May 18, 2026

  • 0 min

Share

Top Institutions in Nephrology

Brief introduction explaining scope and methodology.

  • #1

    Minneapolis VA Health Care System
    Minneapolis VA Health Care System

    Minneapolis, Minnesota

    Key Differentiators

    • Pharmacy

  • #2

    Veterans Affairs (VA) health systems
    Veterans Affairs (VA) health systems

    Various, Various

    Key Differentiators

    • Pharmacy

  • #3

    Chang Gung Memorial Hospital
    Chang Gung Memorial Hospital

    Taoyuan, Taiwan

    Key Differentiators

    • Pharmacy

  • #4

    Taiwan’s National Health Insurance Research Database
    Taiwan’s National Health Insurance Research Database

    Taipei, Taiwan

    Key Differentiators

    • Pharmacy

  • #5

    Montefiore Medical Center
    Montefiore Medical Center

    Bronx, New York

    Key Differentiators

    • Pharmacy

Original Source(s)

Pharmacist Outreach and SGLT2 Inhibitor Uptake in Patients With Diabetes and Chronic Kidney Disease

  • by Deborah L. Pestka, Daniel Murphy, Adam N. Kaplan, Brent C. Taylor, Pearl Huynh, Jessica A. Rechtzigel, Shari Kjos, Lisa Marie Ellich, Melissa Atwood, Beth A. Polsfuss, Amber R. Thomas, Joseph Y. Lee, Areef Ishani

  • May 18, 2026

Related Content

Editorial: Addressing the Challenges of Diabetes Complications and Exploring Innovative Approaches